CA1056381A - 5-ARYL-1,2,3,4-TETRAHYDRO-.gamma.-CARBOLINES - Google Patents

5-ARYL-1,2,3,4-TETRAHYDRO-.gamma.-CARBOLINES

Info

Publication number
CA1056381A
CA1056381A CA223,250A CA223250A CA1056381A CA 1056381 A CA1056381 A CA 1056381A CA 223250 A CA223250 A CA 223250A CA 1056381 A CA1056381 A CA 1056381A
Authority
CA
Canada
Prior art keywords
fluoro
process according
hydrogen
chloro
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA223,250A
Other languages
English (en)
Other versions
CA223250S (en
Inventor
Jacob J. Plattner
James R. Tretter
Charles A. Harbert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Priority to CA314,650A priority Critical patent/CA1067497A/fr
Application granted granted Critical
Publication of CA1056381A publication Critical patent/CA1056381A/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA223,250A 1974-04-01 1975-03-27 5-ARYL-1,2,3,4-TETRAHYDRO-.gamma.-CARBOLINES Expired CA1056381A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA314,650A CA1067497A (fr) 1974-04-01 1978-10-27 LES 5-PHENYL-1,2,3,4-TETRAHYDRO-.gamma.-CARBOLINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45664074A 1974-04-01 1974-04-01

Publications (1)

Publication Number Publication Date
CA1056381A true CA1056381A (fr) 1979-06-12

Family

ID=23813560

Family Applications (1)

Application Number Title Priority Date Filing Date
CA223,250A Expired CA1056381A (fr) 1974-04-01 1975-03-27 5-ARYL-1,2,3,4-TETRAHYDRO-.gamma.-CARBOLINES

Country Status (6)

Country Link
JP (3) JPS5874683A (fr)
BE (1) BE827451A (fr)
CA (1) CA1056381A (fr)
GB (1) GB1476087A (fr)
IE (1) IE41352B1 (fr)
ZA (1) ZA751990B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004063818A (ja) 2002-07-30 2004-02-26 Oki Electric Ind Co Ltd フレキシブルチューブを利用した半導体装置の製造方法
EP2560676B8 (fr) 2010-04-22 2016-10-12 Intra-Cellular Therapies, Inc. Composés organiques
WO2013155504A1 (fr) 2012-04-14 2013-10-17 Intra-Cellular Therapies, Inc. Nouveaux procédés
HUE053159T2 (hu) 2013-03-15 2021-06-28 Intra Cellular Therapies Inc Szerves vegyületek
IL305990B2 (en) 2013-12-03 2025-12-01 Intra Cellular Therapies Inc Long-acting injectable composition comprising polymeric microspheres of heterocycle fused gamma-carboline compounds or a pharmaceutical composition for sustained or delayed release comprising the compounds and their use in the treatment of bipolar disorder i and/or bipolar ii disorder
MX365969B (es) 2014-04-04 2019-06-21 Intra Cellular Therapies Inc Gamma-carbolinas fusionadas con heterociclos sustituidas con deuterio.
RU2016143091A (ru) 2014-04-04 2018-05-08 Интра-Селлулар Терапиз, Инк. Органические соединения
CN108883111B (zh) 2016-01-26 2021-10-08 细胞内治疗公司 有机化合物
PL3407889T3 (pl) 2016-03-25 2021-11-22 Intra-Cellular Therapies, Inc. Związki organiczne i ich zastosowanie w leczeniu lub zapobieganiu zaburzeniom ośrodkowego układu nerwowego
EP3436083A4 (fr) 2016-03-28 2019-11-27 Intra-Cellular Therapies, Inc. Nouvelles compositions et méthodes
US11331316B2 (en) 2016-10-12 2022-05-17 Intra-Cellular Therapies, Inc. Amorphous solid dispersions
US10906906B2 (en) 2016-12-29 2021-02-02 Intra-Cellular Therapies, Inc. Organic compounds
US10961245B2 (en) 2016-12-29 2021-03-30 Intra-Cellular Therapies, Inc. Substituted heterocycle fused gamma-carbolines for treatment of central nervous system disorders
IL268970B2 (en) 2017-03-24 2023-12-01 Intra Cellular Therapies Inc Oral transmucosal formulations of substituted heterocycle fused gamma carbolines
JP7224333B2 (ja) 2017-07-26 2023-02-17 イントラ-セルラー・セラピーズ・インコーポレイテッド 有機化合物
JP7223742B2 (ja) 2017-07-26 2023-02-16 イントラ-セルラー・セラピーズ・インコーポレイテッド 有機化合物
WO2019178484A1 (fr) 2018-03-16 2019-09-19 Intra-Cellular Therapies, Inc. Nouveaux procédés
AU2019240226B2 (en) 2018-03-23 2024-11-28 Intra-Cellular Therapies, Inc. Organic compounds
WO2019237037A1 (fr) 2018-06-08 2019-12-12 Intra-Cellular Therapies, Inc. Nouvelles méthodes
CA3106447A1 (fr) 2018-06-11 2019-12-19 Intra-Cellular Therapies, Inc. Synthese de gamma-carbolines fusionnees a heterocycles substitues
EP3843729A4 (fr) 2018-08-29 2022-06-01 Intra-Cellular Therapies, Inc. Nouvelles compositions et méthodes
CA3108558A1 (fr) 2018-08-31 2020-03-05 Intra-Cellular Therapies, Inc. Nouvelles methodes
CN112584837A (zh) 2018-08-31 2021-03-30 细胞内治疗公司 新方法
IL283963B2 (en) 2018-12-17 2025-01-01 Intra Cellular Therapies Inc Synthesis of condensed gamma-carbolines and converted heterocycles
EP3898580A4 (fr) 2018-12-17 2022-08-10 Intra-Cellular Therapies, Inc. Synthèse de gamma-carbolines fusionnées à hétérocycles substitués
US12195463B2 (en) 2018-12-21 2025-01-14 Intra-Cellular Therapies, Inc. Organic compounds
JP7673040B2 (ja) 2019-07-07 2025-05-08 イントラ-セルラー・セラピーズ・インコーポレイテッド 新規方法
US12414948B2 (en) 2022-05-18 2025-09-16 Intra-Cellular Therapies, Inc. Methods
CN116425670A (zh) * 2022-07-15 2023-07-14 英矽智能科技(上海)有限公司 作为tead抑制剂的新型杂环化合物

Also Published As

Publication number Publication date
GB1476087A (en) 1977-06-10
JPS5874681A (ja) 1983-05-06
JPS5915911B2 (ja) 1984-04-12
IE41352L (en) 1975-10-01
JPS5874682A (ja) 1983-05-06
ZA751990B (en) 1976-02-25
BE827451A (fr) 1975-10-01
JPS5874683A (ja) 1983-05-06
IE41352B1 (en) 1979-12-19

Similar Documents

Publication Publication Date Title
CA1056381A (fr) 5-ARYL-1,2,3,4-TETRAHYDRO-.gamma.-CARBOLINES
US4001263A (en) 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
US4131611A (en) Azabicyclohexanes
US4231935A (en) 1-Phenyl-3-azabicyclo[3.1.0]hexanes
US4072686A (en) 1-(3,3,3-Triarylalkyl)-4-phenyl-piperidinealkanols
US4224329A (en) 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4582909A (en) Benzobicyclic lactam acids and derivatives as cognition activators
US4048182A (en) Derivatives of imidazo [4,5-b]pyridines
SU873883A3 (ru) Способ получени гексагидро - -карболинов или их солей
FI71936B (fi) Foerfarande foer framstaellning av neuroleptiskt aktiva 2-substituerade-8-fluor-5-(4-fluorfenyl)-2,3,4,4a 5,9b-hexahydro-4a 9b-trans-1h-pyrido/4,3-b/indolderivat
CA1255306A (fr) Composes d'octahydro-indolizine utiles comme analgesiques
EP0076035B1 (fr) Dérivés de la pyrazolo(3,4-b)pyridine
US4375471A (en) 4-Aryloxy-1,2,3,4-tetrahydroisoquinolines
EP0083222B1 (fr) Acides quinoléinylacétiques et compositions pharmaceutiques les contenant
US4677112A (en) 1,2,3,4-tetrahydro-2-oxo-8-quinolineacetic and -propanoic acids and derivatives as cognition activators
CA1133483A (fr) Agents neuroleptiques a base d'hexahydro-trans- pyridoindole
US4252812A (en) 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4267331A (en) Process for the production of 2-substituted pyrido[4,3-b]-indoles
US4156730A (en) Pharmaceutically active compounds, preparation thereof, intermediates useful in such preparation and compositions containing the compounds
US4044137A (en) 2-(Phenylthiopropyl)-5-aryl-1,2,3,4-tetrahydro-γ-carbolines
CA1055949A (fr) 4-aryl-1,2,3,4-tetrahydropyrrolo(3,4-b) indoles
US3862947A (en) Intermediate for production of alkoxy derivatives of pyrazolopyridine carboxylic acids and esters
JPS587635B2 (ja) インドリンカゴウブツノセイゾウホウ
US4006164A (en) 4-Aryl-1,2,3,4-tetrahydropyrrolo[3,4-b]indoles
US3968231A (en) 4-Aryl-1,2,3,4-tetrahydropyrrolo(3,4-b)indoles for treating schizophrenic manifestations